Cardiovascular Outcome Trials Patients with Diabetes

Potential Mechanisms of CV Risk Reductions

Friday, April 26
2:25 PM - 2:55 PM
Location: Convention Center 502 A

Richard Pratley, MD

Medical Director, AdventHealth Diabetes Institute, and Senior Investigator and Diabetes Program Lead, Translational Research Institute for Metabolism and Diabetes
AdventHealth

Richard Pratley, MD serves as the Medicall Director at the AdventHealth Diabetes Institute, as well as Senior Investigator and Diabetes Program Lead at the Translational Research Institute for Metabolism and Diabetes, both in Orlando, FL. He is board certified in internal medicine, received his medical degree from Wayne State University in Detroit, and completed fellowships in geriatric medicine and gerontology at the University of Michigan, John Hopkins University, and the National Institute on Aging. Dr. Pratley is an internationally recognized expert in diabetes. He lectures frequent, has conducted numerous research studies on the pathogenesis, prevention and treatment of diabetes, and has published over 230 peer-reviewed articles on diabetes. Dr. Pratley is currently a member of the editorial boards of The Lancet: Diabetes and Endocrinology, The Journal of Clinical Endocrinology & Metabolism, The Journal of Diabetes and Complications and Reviews of Diabetes Studies.

Presentation(s):

Send Email for Richard Pratley


Assets

Potential Mechanisms of CV Risk Reductions

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Potential Mechanisms of CV Risk Reductions